Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy
Yoon-Kyoung Sung, Soo-Kyung Cho, Dam Kim, Soyoung Won, Chan-Bum Choi, Tae-Hwan Kim, Jae-Bum Jun, Dae-Hyun Yoo, Sang-Cheol Bae
Korean J Intern Med. 2018;33(5):1016-1024.   Published online 2017 Mar 13     DOI: https://doi.org/10.3904/kjim.2016.214
Citations to this article as recorded by Crossref logo
Isoniazid/tumor necrosis factor inhibitors
Reactions Weekly.2018; 1723(1): 181.     CrossRef